Breo ellipta and Drooling - a phase IV clinical study of FDA data

Summary:

Drooling is reported as a side effect among people who take Breo ellipta (fluticasone furoate; vilanterol trifenatate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ingrezza, and have Clinically isolated syndrome.

The phase IV clinical study analyzes which people have Drooling when taking Breo ellipta. It is created by eHealthMe based on reports of 37,063 people who have side effects when taking Breo ellipta from the FDA, and is updated regularly.

What is Breo ellipta?

Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in asthma. eHealthMe is studying from 37,362 Breo ellipta users. Check the latest studies of Breo ellipta.

What is Drooling?

Drooling (drop saliva uncontrollably from the mouth) is found to be associated with 497 drugs and 941 conditions by eHealthMe. Check the latest studies of Drooling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

37,063 people reported to have side effects when taking Breo ellipta.
Among them, 13 people (0.04%) have Drooling.

Among these 13 people:

How long have people been on Breo ellipta when they have Drooling? *

What is the gender of people who have Drooling when taking Breo ellipta? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Drooling when taking Breo ellipta? *

What are other drugs people take besides Breo ellipta? *

Xanax: 6 people, 46.15%
Ingrezza: 6 people, 46.15%
Aspirin: 5 people, 38.46%
Crestor: 5 people, 38.46%
Hydrochlorothiazide: 4 people, 30.77%
Naltrexone Hydrochloride: 4 people, 30.77%
Meloxicam: 4 people, 30.77%
Kesimpta: 4 people, 30.77%
Plaquenil: 4 people, 30.77%
Jardiance: 4 people, 30.77%

What are other side effects people have besides Drooling? *

Fatigue (feeling of tiredness): 7 people, 53.85%
Pain: 7 people, 53.85%
Influenza Like Illness: 4 people, 30.77%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 30.77%
Headache (pain in head): 4 people, 30.77%
Gait Disturbance: 4 people, 30.77%
Folliculitis (infection of hair root): 4 people, 30.77%
Back Pain: 3 people, 23.08%
Cough: 3 people, 23.08%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 15.38%

What are the existing conditions these people have? *

Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 30.77%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 30.77%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 30.77%
Tardive Dyskinesia (a disorder that involves involuntary movements): 4 people, 30.77%
Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 4 people, 30.77%
Urinary Tract Infection: 1 person, 7.69%
Depression: 1 person, 7.69%
Bipolar Disorder (mood disorder): 1 person, 7.69%
Breakthrough Pain: 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Breo ellipta and have Drooling?

- Check whether Drooling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Breo ellipta:

Breo ellipta (37,362 reports)

Drooling treatments and more:

Drooling (8,115 reports)

How severe was Drooling and when was it recovered:

Drooling in Breo ellipta

Expand to all the drugs that have ingredients of fluticasone furoate; vilanterol trifenatate:

Drooling and drugs with ingredients of fluticasone furoate; vilanterol trifenatate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Breo ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drooling:

Drooling (497 drugs)

Browse all the conditions that are associated with Drooling:

Drooling (941 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate; vilanterol trifenatate (the active ingredients of Breo ellipta) and Breo ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.